Wolfe Research Downgrades Ionis Pharmaceuticals to Peer Perform

Benzinga · 2d ago
Wolfe Research analyst Andy Chen downgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Outperform to Peer Perform.